Bristol-Myers Squibb Company
Antibodies against MICA and/or MICB and uses thereof
Last updated:
Abstract:
The disclosure provides antibodies that specifically bind human MICA/B and methods of use thereof. In some aspects, the disclosure is directed to methods of treating a cancer in a subject, comprising administering to the subject an anti-MICA/B antibody.
Status:
Grant
Type:
Utility
Filling date:
22 Mar 2019
Issue date:
8 Feb 2022